Genentech GA45767

Study Name: Genentech GA45767

Phase 1, SLE

Up to 15 LuCIN sites (U.S. and Canada)

Active, Not recruiting

Other News

Can diet make a difference in lupus?

An IDEAL Initiative in Lupus Research: Q&A With Dr. Stacie J. Bell, Lupus Therapeutics, and Dr. Teodora Staeva, Lupus Research Alliance

Could diet and gut health impact the lived experience of lupus? This intriguing question lies at the heart of...

Breaking news: Gazyva for Lupus Nephritis

FDA Accepts Application for Potential Treatment for Lupus Nephritis, Gazyva®

Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is eager to share exciting news. The U.S....

Breaking News

Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study

February 7, 2025

Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at...